Clinical characteristics of vertigo in elderly patients with chronic brain ischemia after SARS‑CoV‑2 coronavirus infection
https://doi.org/10.33667/2078-5631-2023-14-32-35
Abstract
Objective. To study the structure and clinical features of vertigo in elderly patients with chronic cerebral ischemia (CCI) who underwent a new SARS-CoV-2 coronavirus infection.
Materials and methods. Clinical characteristics of vertigo were determined in 98 patients (48 men and 50 women aged 60–75 years) with CCI caused by arterial hypertension and its combination with atherosclerosis. The type and main characteristics of dizziness were determined using diagnostic criteria and an algorithm for examining patients. The level of anxiety was determined using the scale of Spielberger, depression – the Beck questionnaire.
Results. Dizziness in elderly patients with CCI was characterized by clinical heterogeneity with a predominance of non-systemic vertigo and systemic benign paroxysmal positional vertigo in the structure of vertigo. Elderly patients with CCI who underwent a new SARS-CoV-2 coronavirus infection were more likely to have psychogenic and systemic benign paroxysmal positional vertigo, increased levels of anxiety and depression.
About the Authors
L. V. Chichanovskaya
Tver State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
Lesya V. Chichanovskaya - DM Sci (habil.), professor, head of Dept of Neurology, Rehabilitation and Neurosurgery.
Tver
T. A. Slyusar
Tver State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
Tatyana A. Slyusar - DM Sci (habil.), professor.
Tver
Yu. V. Abramenko
Tver State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
Yuliya V. Abramenko - PhD Med, associate professor.
Tver
T. M. Nekrasova
Tver State Medical University of the Ministry of Health of Russia
Russian Federation
Russian Federation
Tatyana M. Nekrasova - PhD Med, assistant.
Tver
References
1. Putilina M. V., Grishin D. V. SARS-CoV-2 (COVID-19) as a predictor of neuroinflammation and neurodegeneration: potential therapy strategies. J of Neurology and Psychiatry n.a. S. S. Korsakov. 2020; 120 (8): 58–64.
2. Carod-Artal F. J. Neurological complications of coronavirus and COVID-19. Complicaciones neurológicas por coronavirus y COVID-19. Rev Neurol. 2020; 70 (9): 311–322. DOI: 10.33588/rn.7009.2020179.
3. Fedin A. I. Neurological clinical pathology associated with COVID-19. Available at: http://neuronews.ru/index.php/rubriki/glavnaya-tema/item/3701-nevrologicheskaya-klinicheskaya-patologiya-assotsiirovannaya-s-covid-19 (date of access – 01.08.2020).
4. Devita M., Bordignon A., Sergi G. et al. The psychological and cognitive impact of Covid-19 on individuals with neurocognitive impairments: Research topics and remote intervention proposals. Aging Clin Exp Res 33, 733–736 (2021). https://doi.org/10.1007/s40520–020–01637–6
5. Kadjikov AS, Manvelov LS, Shahparonova NI. Chronic vascular diseases of the brain encephalopathy. Guide for doctors. 3rd edition, revised and expanded. M., 2014.
6. Parfenov VA, Zamergrad MV, Melnikov OA. Dizziness: Diagnosis and treatment, common mistakes. M., 2009. 152 p.
7. Sheremet AS. Dizziness. Consilium Medicum. 2001. Supplement. pp. 3–8.
8. Brandt T. Vertigo. Its Multicensory Syndromes. 2nd Ed. London, 2000. 441–451.
9. Spilberger CD, Gorsuch RL, Lushene RE. Manual for the State-Trait Anxiety Inventory. Palo Alto, 1970. 45 с.
10. Beck AT, Ward CH, Henderson H. An inventory for measuring depression. Arch. Gen. Psichiatr. 1961. 5. 561–571.
11. Tupe MO. The main diagnoses for dizziness and balance disorders. M., 2002. 36 p.
12. Eliseev EV. Correction of dizziness in patients with cerebral ischemia. Russian Medical Journal. 2008.16. 1087–1092.
13. Golubev VL. Dizziness. Treatment of nervous diseases. 2003. 4, 2. 3–9.
14. Brandt Т, Bronstein АМ. Cervical vertigo. J. Neural. Neurosurg. Psychiatry. 2001. 71. 8–12.
15. Voznesenskaya TG, Golubev VL, Dyukova GM. Depression in neurological practice. M., 2007. 208 p.
16. Gorbacheva FE, Matveeva LA, Chuchin MYu. About cervical dizziness. Russian Medical Journal. 2004. 12, 10. 578–581.
17. Dadasheva MN. Autonomic disorders and new approaches to their correction in vertebrogenic dizziness. 2004. 11, 4. 90–91.
18. Tabeeva GR, Vein AM. Dizziness in psychovegetative syndromes. Consilium Medicum. 2001. 4, 15. 15–16.
19. Tolmacheva VA. Dizziness in patients with arterial hypertension. Doctor.2005.11. 60–62.
20. Kalinkin MN, Yakovlev NA, Slyusar TA. Chronic cerebral ischemia in old age (pathogenetic and clinical aspects). Tver, 2016. 226 p.
21. Damulin IV, Parfenov VA, Skoromets AA, Yakhno NN. Circulatory disorders in the brain and spinal cord. Diseases of the nervous system: A guide for doctors. M., 2001: 1. 231–302.
22. Neuhauser H. K. Epidemiology of vertigo. Curr. Opin. Neurol. 2007. 20. P. 40–60.
Review
For citations:
Chichanovskaya L.V., Slyusar T.A., Abramenko Yu.V., Nekrasova T.M. Clinical characteristics of vertigo in elderly patients with chronic brain ischemia after SARS‑CoV‑2 coronavirus infection. Medical alphabet. 2023;(14):32-35. (In Russ.) https://doi.org/10.33667/2078-5631-2023-14-32-35
Views:
130
Email this article 